Flagship explainer
What drives GUIDED THERAPEUTICS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$3.2M | FY2025 |
| |
| Income before tax | −$3.2M | FY2025 |
|
| Operating income | −$2.4M | FY2025 |
|
| $767000 | FY2025 |
| |
| Ending assets | $1.3M | FY2025 |
|
| Beginning assets | $1.4M | FY2024 |
|
| −$6M | FY2025 |
| |
| −$4.9M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001477932-26-001723